AIDS researchers have for the first time demonstrated that human blood stem cells can be engineered into cells that can target and kill HIV-infected cells — a process that potentially could be used against a range of chronic viral diseases. The study, published today in PLoS ONE, demonstrates that human stem cells can be engineered into the equivalent of a genetic vaccine.
By Taking CD8 cytotoxic T lymphocytes — the "killer" T cells that help fight infection — from an HIV-infected individual, the researchers identified the molecule known as the T-cell receptor, which guides the T cell in recognizing and killing HIV-infected cells.
These cells, while able to destroy HIV-infected cells, do not exist in enough quantities to clear the virus from the body. So the researchers cloned the receptor and genetically engineered human blood stem cells, then placed the stem cells into human thymus tissue that had been implanted in mice, allowing them to study the reaction in a living organism.
The engineered stem cells developed into a large population of mature, multifunctional HIV-specific CD8 cells that could specifically target cells containing HIV proteins. The researchers also found that HIV-specific T-cell receptors have to be matched to an individual in much the same way that an organ is matched to a transplant patient.
"We have demonstrated in this proof-of-principle study that this type of approach can be used to engineer the human immune system, particularly the T-cell response, to specifically target HIV-infected cells," said lead investigator Scott G. Kitchen, assistant professor of medicine in the division of hematology and oncology at UCLA.
"These studies lay the foundation for further therapeutic development that involves restoring damaged or defective immune responses toward a variety of viruses that cause chronic disease, or even different types of tumors."
The next step is to test this strategy in a more advanced model to determine if it would work in the human body, said co-author Jerome A. Zack, UCLA professor of medicine in the division of hematology and oncology and associate director of the UCLA AIDS Institute. The researchers also hope to expand the range of viruses against which this approach could be used.
Citation: Kitchen SG, Bennett M, Galić Z, Kim J, Xu Q, et al., 'Engineering Antigen-Specific T Cells from Genetically Modified Human Hematopoietic Stem Cells in Immunodeficient Mice', PLoS ONE 2009, 4(12): e8208. doi:10.1371/journal.pone.0008208
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- The Science Behind Distillation
- New Results From The LHC At 13 TeV!
- How Did Mexico Eliminate Breast Cancer Deaths?
- 3D Printed ‘Smart Cap’ Can Detect Spoiled Food
- Epigenetics: Quackery Or Phenomenon?
- No other way
- Kepler 452b - Things That Could Go Wrong With Habitability & If It Is - Could We Detect Intelligent Life There?
- "Question: Are there 2 data points missing in the mT plot? and surely the high mT 'excess' has got..."
- "I think Omoo is a fine word. But Pluto may not like it regardless, because 2% of astronomers may..."
- "Not cool Tommaso. :) I take that means the excess disappeared at 13 tev. ..."
- "Ah, that - I guess at 13 TeV it will become a 3.2 TeV excess ;-)Cheers,T...."
- "This is way off topic, but Bush tried to fix the problem about 15 years ago for my generation and..."